Stay updated on Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.

Latest updates to the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page
- CheckyesterdayChange DetectedResults First Posted on 2025-05-23 and updated study dates have been added to the page. This provides the study outcomes and current status for NCT03739996.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference2%

- Check29 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check43 days agoChange Detected- Revision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. Overall, there are no changes to core content, pricing, stock, time slots, or proper nouns.SummaryDifference0.1%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check58 days agoChange DetectedThe web page has updated its facility name and location details, while also adding new publications related to HIV treatments and drug information for Cabotegravir. Notably, several previous terms and classifications related to HIV medications have been removed.SummaryDifference4%

Stay in the know with updates to Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.